An artistic rendering of AION Healthspan`s REJUVXL Cell Therapy for Chronic Kidney Disease. AION Healthspan announces enrollment for its fi ...
The personalized cancer vaccine trial conducted by Yale University offers promising results for patients with advanced kidney ...
More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
A study from the University of Hyderabad reveals that over 80% of IT employees in India suffer from fatty liver disease.
You might experience other health effects if you don't manage prediabetes effectively, possibly affecting your eyes, heart, ...
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway ...
News Medical on MSN5d
New insights into mTOR pathway offer hope for diabetic nephropathy treatmentA newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
News Medical on MSN10d
Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarringbut could also lead to treatments that halt or even reverse lung scarring in the disease." Global early-phase clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback